NCT02848469

Irish Omega-3 Study

Randomized Control Trial of Omega-3 Fatty Acids Compared to Placebo in the Prevention of Psychosis in Very High Risk Individuals

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 150 (estimated)
• Sponsor: University College Cork · Academic / Other
• Sex: All
• Age: 13 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The Irish Omega-3 study is a clinical trial designed to investigate the potential of Omega-3 fatty acids in the reduction of risk of psychosis. The study is being coordinated by the HRB Clinical Research Facility at University College Cork. The Principal Investigator is Dr Maeve Rooney, Consultant Psychiatrist in the Mercy University Hospital, Cork. The study will be carried out in collaboration with the HRB Clinical Research Facility in Dublin in prior to rolling out to other centres around Ireland. The Study is funded by Stanley Medical Research Institute, a non-profit organization supporting research on the causes of, and treatments for, schizophrenia and bipolar disorder. It is the largest provider of funding for research in serious mental illness outside of the U.S. government.

Conditions

• Psychotic Disorders

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	1000mg of eicosapentaenoic acid and 1000mg docosahexaenoic acid

Timeline

• Start date: 2013-09-01
• Primary completion: 2018-02-01
• Completion: 2018-02-01
• First posted: 2016-07-28
• Last updated: 2016-07-28

Locations

1 site across 1 country: Ireland